Integrated approaches enhance clinical translation of PTP1B inhibitors for Type 2 diabetes, indicating significance for treatment.
The development of PTP1B inhibitors requires integrated approaches that include allosteric modulation, tissue-specific delivery, and patient stratification to achieve successful clinical translation across multiple disease indications.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: